Dr. Stephen J. Murphy, MD
Rheumatology (Rheumatology Physician)
- Medicare participating
At a glance
- Medical school
- New York Medical College (2003)
- Years since graduation
- 23
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 485
Licensed in Colorado since 2006, according to the Colorado Department of Regulatory Agencies. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2003Medical school: New York Medical College
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Rheumatology Physician primary
CO license 44784 (first issued 2006; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- The Medical Center of Aurora & South Hospital Aurora, CO
- HCA Healthone Rose Denver, CO
- Heart of the Rockies Regional Medical Center Salida, CO
Medical groups
- Denver Health and Hospital Authority (849 clinicians)
- Denver Arthritis Clinic PC (13 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 485
- Services billed
- 93,206
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Injection, golimumab, 1 mg, for intravenous use | 14,500 | 32 |
| Injection, tocilizumab, 1 mg | 12,760 | 12 |
| Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 9,750 | 36 |
| Injection, infliximab, excludes biosimilar, 10 mg | 8,800 | 43 |
| Injection, romosozumab-aqqg, 1 mg | 7,350 | 11 |
| Injection, denosumab, 1 mg | 6,000 | 75 |
| Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | 3,910 | 18 |
| Injection, rituximab, 10 mg | 3,400 | 11 |
| Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg | 1,320 | 16 |
| Established patient office or other outpatient visit, 30-39 minutes | 615 | 288 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Methotrexate (methotrexate sodium) Other prescribers in Denver, CO | 419 |
| Prednisone Other prescribers in Denver, CO | 380 |
| Hydroxychloroquine Sulfate Other prescribers in Denver, CO | 170 |
| Tramadol Hcl Other prescribers in Denver, CO | 148 |
| Meloxicam Other prescribers in Denver, CO | 118 |
| Alendronate Sodium Other prescribers in Denver, CO | 113 |
| Leflunomide Other prescribers in Denver, CO | 99 |
| Allopurinol Other prescribers in Denver, CO | 97 |
| Cyclobenzaprine Hcl Other prescribers in Denver, CO | 85 |
| Hydrocodone-Acetaminophen (hydrocodone/acetaminophen) Other prescribers in Denver, CO | 72 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 5 companies reported 15 payments worth $299 in total to this clinician.
| Novartis Pharmaceuticals Corporation | $136 |
|---|---|
| Amgen Inc. | $93.17 |
| Genzyme Corporation | $31.34 |
| E.r. Squibb & Sons, L.l.c. | $22.71 |
| GlaxoSmithKline, LLC. | $15.69 |
| Food and Beverage | $299 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.